We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours

By LabMedica International staff writers
Posted on 04 Feb 2021
Print article
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)
A new COVID-19 test robot can process up to 20,000 samples for SARS-CoV-2 testing per 24 hours, making it much faster than all other systems used to date.

The robot, called STRIP-1, developed by scientists at the Hubrecht Institute (Utrecht, the Netherlands) and Genmab (Copenhagen, Denmark) can not only process more tests in less time than any other machine known to date, but can also track all samples precisely, because they have a barcode that is scanned multiple times throughout the process. This also enables an automatic online return of test results to the tested persons. Because STRIP-1 can work with very small volumes, it uses less of the materials that are currently very scarce across the world. The costs per test will also be much lower than current testing costs. Lastly, using STRIP-1 will relieve overloaded laboratory personnel.

After successfully going through the validation procedure, the robot will be used for large scale testing. The Dutch government plans to order five more of such robots in the future, if the validation procedure indeed delivers the expected results. Together, these robots will be able to process more than 100,000 samples per 24 hours. The robots are not only useful during the current COVID-19 pandemic, but due to their modular structure, they can also be used for future pandemics. This enables large scale testing immediately, without overloading the regular diagnostic laboratories.

“While we were working on this, we realized that the gold standard of tests, the PCR test, works extremely well and that the biggest challenge was the logistics of it all,” said Wouter de Laat, one of the initiators of the project. “We hoped that we could organize everything in a faster and more intelligent way by using robots, so that became our focus almost immediately.”

Related Links:
Hubrecht Institute
Genmab


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.